medsynapse-hcp
Introduction: Primary Progressive Multiple Sclerosis (PPMS) is characterised by a gradual accumulation of disability from disease onset, without relapses (1). This form of multiple sclerosis presents significant therapeutic challenges due to the absence of approved disease-modifying therapies (DMTs) (1). The pathophysiology of PPMS involves central
Efficacy and Safety of Tolebrutinib in Primary Progressive Multiple Sclerosis: Insights from the PERSEUS Phase 3 Trial

Efficacy and Safety of Tolebrutinib in Primary Progressive Multiple Sclerosis: Insights from the PERSEUS Phase 3 Trial

909 Reached3 Comments

Similar Content

Fremanezumab for Prevention and Treatment of Migraine
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Young Girl Presented with Irritability and Abnormal Behavior
Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes
Spinal Anesthesia in Elderly Patient
Spinal Anesthesia in Elderly Patient
4200 Reached10 Comments7 Likes
Unconscious Male in ED following Loss of Motorcycle Control
Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes
Neurotrophic Deep Corneal Ulcer in Old Male
Neurotrophic Deep Corneal Ulcer in Old Male
1139 Reached5 Comments4 Likes